Press Release Bristol Myers Squibb’s CAR T Cell Therapy Breyanzi Approved by the U.S. Food and Drug Administration for Relapsed or Refractory Follicular Lymphoma 16 May 2024
Press Release InnoCare Announces the Completion of Patient Enrollment in the Phase II Clinical Trial of ICP-488 for the Treatment of Psoriasis 16 May 2024
Press Release Oasis Calls for Improved Shareholder Return & Votes Against Chairman, Two Directors at Kumagai Gumi 15 May 2024
Press Release Charleston Digital Corridor welcomes Irish trailblazers Fexillon to thriving tech community 15 May 2024
Press Release New Award Programme From Oral-B and the International Association for Disability and Oral Health (iADH) Champions Disability Positive Dental Practices Across Europe 15 May 2024
Press Release CORRECTING and REPLACING Artemis Health Announces Winners of the 2023 Client Awards 15 May 2024
Press Release State Street Corporation Declares Dividends on its Common Stock and Non-Cumulative Perpetual Preferred Stock Series “G,” “H,” and “I” 15 May 2024
